Almost three-fourths of patients with biochemically recurrent prostate cancer remained metastasis free at 5 years following ...

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...

New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...

Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment ...

—As more men are cured of prostate cancer, or are long-term survivors, the challenges of survivorship are in the spotlight. Improved screening practices, earlier detection, and better therapies have ...

City of Hope ® , one of the largest and most advanced cancer research and treatment organizations in the United States with ...